124 related articles for article (PubMed ID: 16144984)
1. Nongenomic effects of aldosterone in the human heart: interaction with angiotensin II.
Chai W; Garrelds IM; de Vries R; Batenburg WW; van Kats JP; Danser AH
Hypertension; 2005 Oct; 46(4):701-6. PubMed ID: 16144984
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase.
Batenburg WW; Jansen PM; van den Bogaerdt AJ; J Danser AH
Cardiovasc Res; 2012 Apr; 94(1):136-43. PubMed ID: 22260839
[TBL] [Abstract][Full Text] [Related]
3. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone nongenomically worsens ischemia via protein kinase C-dependent pathways in hypoperfused canine hearts.
Fujita M; Minamino T; Asanuma H; Sanada S; Hirata A; Wakeno M; Myoishi M; Okuda H; Ogai A; Okada K; Tsukamoto O; Koyama H; Hori M; Kitakaze M
Hypertension; 2005 Jul; 46(1):113-7. PubMed ID: 15956114
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone?
Chai W; Garrelds IM; de Vries R; Danser AH
Hypertension; 2006 Apr; 47(4):665-70. PubMed ID: 16490840
[TBL] [Abstract][Full Text] [Related]
6. Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries.
Schuijt MP; Tom B; de Vries R; Saxena PR; Sluiter W; van Kats JP; Danser AH
J Hypertens; 2003 Dec; 21(12):2335-44. PubMed ID: 14654755
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.
Min LJ; Mogi M; Li JM; Iwanami J; Iwai M; Horiuchi M
Circ Res; 2005 Sep; 97(5):434-42. PubMed ID: 16081869
[TBL] [Abstract][Full Text] [Related]
8. Eplerenone blocks nongenomic effects of aldosterone on the Na+/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels.
Michea L; Delpiano AM; Hitschfeld C; Lobos L; Lavandero S; Marusic ET
Endocrinology; 2005 Mar; 146(3):973-80. PubMed ID: 15550504
[TBL] [Abstract][Full Text] [Related]
9. Rapid effects of aldosterone on clonal human vascular smooth muscle cells.
Gros R; Ding Q; Armstrong S; O'Neil C; Pickering JG; Feldman RD
Am J Physiol Cell Physiol; 2007 Feb; 292(2):C788-94. PubMed ID: 16971490
[TBL] [Abstract][Full Text] [Related]
10. Inotropic effects of angiotensin II on human cardiac muscle in vitro.
Moravec CS; Schluchter MD; Paranandi L; Czerska B; Stewart RW; Rosenkranz E; Bond M
Circulation; 1990 Dec; 82(6):1973-84. PubMed ID: 2242522
[TBL] [Abstract][Full Text] [Related]
11. Rapid effects of aldosterone and spironolactone in the isolated working rat heart.
Barbato JC; Mulrow PJ; Shapiro JI; Franco-Saenz R
Hypertension; 2002 Aug; 40(2):130-5. PubMed ID: 12154102
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.
Mazak I; Fiebeler A; Muller DN; Park JK; Shagdarsuren E; Lindschau C; Dechend R; Viedt C; Pilz B; Haller H; Luft FC
Circulation; 2004 Jun; 109(22):2792-800. PubMed ID: 15159288
[TBL] [Abstract][Full Text] [Related]
13. Role of phosphoinositide 3-kinase {alpha}, protein kinase C, and L-type Ca2+ channels in mediating the complex actions of angiotensin II on mouse cardiac contractility.
Liang W; Oudit GY; Patel MM; Shah AM; Woodgett JR; Tsushima RG; Ward ME; Backx PH
Hypertension; 2010 Sep; 56(3):422-9. PubMed ID: 20696985
[TBL] [Abstract][Full Text] [Related]
14. The cardiac effects of intracoronary angiotensin II infusion.
Broomé M; Haney M; Osterlund B; Häggmark S; Johansson G; Biber B
Anesth Analg; 2002 Apr; 94(4):787-93, table of contents. PubMed ID: 11916774
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes.
Rude MK; Duhaney TA; Kuster GM; Judge S; Heo J; Colucci WS; Siwik DA; Sam F
Hypertension; 2005 Sep; 46(3):555-61. PubMed ID: 16043662
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
Oestreicher EM; Martinez-Vasquez D; Stone JR; Jonasson L; Roubsanthisuk W; Mukasa K; Adler GK
Circulation; 2003 Nov; 108(20):2517-23. PubMed ID: 14581407
[TBL] [Abstract][Full Text] [Related]
17. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
Schwinger RH; Böhm M; Schulz C; Schmidt U; Schmidt U; Schmid B; Dienemann H; Reichart B; Erdmann E
J Pharmacol Exp Ther; 1993 Apr; 265(1):346-57. PubMed ID: 8386240
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells.
Christ M; Günther A; Heck M; Schmidt BM; Falkenstein E; Wehling M
Circulation; 1999 Mar; 99(11):1485-91. PubMed ID: 10086974
[TBL] [Abstract][Full Text] [Related]
19. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
[TBL] [Abstract][Full Text] [Related]
20. Effects of low-flow ischemia on the positive inotropic action of angiotensin II in isolated rabbit and rat hearts.
Libonati JR; Eberli FR; Sesselberg HW; Apstein CS
Cardiovasc Res; 1997 Jan; 33(1):71-81. PubMed ID: 9059530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
